<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[aventis Resources | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/aventis.html]]></link>
	<description><![CDATA[White papers, case studies, business articles, and blog posts relating to aventis]]></description>
	<s:counts start="0" returned="20" found="514" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Nanomedicine company Nanobiotix elects former Aventis vice chairman and CFO Patrick Langlois as its chairman]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2008_May_12/ai_n25405331]]></link>
		<description><![CDATA[Podcast available at www.medtechmatters.com]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 12 May 2008 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Aventis Pays More Than $190 Million to Settle Drug Pricing Fraud Matters]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5554/is_200709/ai_n21908465]]></link>
		<description><![CDATA[To: NATIONAL EDITORSTo: NATIONAL EDITORS]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 10 Sep 2007 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/pricing+strategy.html"><![CDATA[pricing strategy]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Kingsley & Kingsley, APC and Joseph & Herzfeld LLP Announces New Lawsuit Filed Against Sanofi -Aventis U.S. for Failure to Pay Pharmaceutical Reps Overtime]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2007_Jan_9/ai_n27107693]]></link>
		<description><![CDATA[Ten Major Drug Companies Now Face Class Action Suits for Violating Federal and State Labor Laws]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 09 Jan 2007 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/american+power+conversion+corp..html"><![CDATA[American Power Conversion Corp.]]></category>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[UB pledges Aventis stake to raise $40m for airline.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5936/is_200609/ai_n23949841]]></link>
		<description><![CDATA[Byline: Boby Kurian    Byline: Boby Kurian  ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 24 Sep 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Plavix litigation settlement agreement amended.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6487/is_200606/ai_n25822172]]></link>
		<description><![CDATA[Sanofi- Aventis (Paris, France) and Bristol- Myers Squibb (New  York, NY) and Apotex, Inc. and Apotex Corporation (Toronto, Canada)  announced that in response to concerns raised by the Federal Trade  Commission ("FTC") and state attorneys general to the  previously announced proposed settlement the companies reached with...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 01 Jun 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/agreement.html"><![CDATA[agreement]]></category>
		<category domain="http://resources.bnet.com/topic/attorney.html"><![CDATA[attorney]]></category>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/ftc.html"><![CDATA[FTC]]></category>
		<category domain="http://resources.bnet.com/topic/litigation.html"><![CDATA[Litigation]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Oscient Pharmaceuticals Hires Philippe M. Maitre as Senior Vice President and Chief Financial Officer; Former CFO of PPD and Former Deputy CFO of Aventis; Stephen Cohen Announces Retirement after Five Years of Dedicated Service]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2006_May_22/ai_n16374204]]></link>
		<description><![CDATA[WALTHAM, Mass. -- Oscient Pharmaceuticals Corporation (Nasdaq: OSCI) has hired Philippe M. Maitre as Senior Vice President and Chief Financial Officer. As a senior executive with over 25 years experience at several leading biotechnology, pharmaceutical and contract research organizations, Mr. Maitre brings significant U.S. and global finance and business management...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 22 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/pharmaceutical+company.html"><![CDATA[pharmaceutical company]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Winner of Aventis Prize for popular science writing announced]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0KNB/is_2006_May_18/ai_n24987223]]></link>
		<description><![CDATA[M2 BEST BOOKS-C2000-2006 M2 COMMUNICATIONS LTD]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 18 May 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Shortlist for Royal Society's Aventis General Prize announced]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0KNB/is_2006_April_18/ai_n24985228]]></link>
		<description><![CDATA[M2 BEST BOOKS-C2000-2006 M2 COMMUNICATIONS LTD]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 18 Apr 2006 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[CHEMICALS : DEGUSSA GETS METHIONINE CARTEL FINE REDUCED.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb6637/is_200604/ai_n26518153]]></link>
		<description><![CDATA[The European Union's Court of First Instance decided on 5  April to reduce the fine imposed by the European Commission  in 2002 on  Degussa for an illegal agreement by  27 million, cutting the overall  penalty from  118.1 to 91.1 million (case T-279/02). The Court...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 13 Apr 2006 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/chemicals.html"><![CDATA[chemicals]]></category>
		<category domain="http://resources.bnet.com/topic/commission.html"><![CDATA[commission]]></category>
		<category domain="http://resources.bnet.com/topic/european+commission.html"><![CDATA[European Commission]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[SALES]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Longlist for Aventis general prize announced]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0KNB/is_2006_March_16/ai_n24983759]]></link>
		<description><![CDATA[M2 BEST BOOKS-C2000-2006 M2 COMMUNICATIONS LTD]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Thu, 16 Mar 2006 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sanofi-Aventis is optimistic after strong third quarter]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200511/ai_n15748609]]></link>
		<description><![CDATA[PARIS AFP &#8212; French healthcare group Sanofi-Aventis announced that net profit in the third quarter of the year had risen sharply and that the company was on track to meet its target of a 20-percent rise in earnings per share this year.  The company said that adjusted net profit...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 08 Nov 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/paris.html"><![CDATA[Paris]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Leerink Swann & Company Initiates Coverage of Sanofi- Aventis SA (NYSE: SNY) and (Paris: SAN)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_pwwi/is_200508/ai_n14942152]]></link>
		<description><![CDATA[Yesterday after the close, Senior Pharmaceuticals Analyst, Andrew Oh, initiated coverage of Sanofi-Aventis SA with a Market Perform rating.  Despite projected double-digit near-term earnings growth (16% in 2005 and 12% in 2006) and two potential blockbuster launches Acomplia and Exubera, he believes that the company is fairly valued at...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Fri, 26 Aug 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/san.html"><![CDATA[SAN]]></category>
		<category domain="http://resources.bnet.com/topic/nyse+euronext.html"><![CDATA[NYSE Euronext]]></category>
	</item>
	<item>
		<title><![CDATA[Aventis Pharma Obtains Additional Approval for Taxoid Antitumor Agent]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qn6209/is_20050822/ai_n24408570]]></link>
		<description><![CDATA[Tokyo, Aug 22, 2005 - JCN - Aventis Pharma of the sanofi- aventis Group announced on August 19 that it has obtained additional approval for TAXOTERE Injection, its proprietary taxoid antitumor agent, from the Ministry of Health, Labor and Welfare as of August 18. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 22 Aug 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[The Aventis prize.(for science book 'Critical Mass: How One Thing Leads to Another')(Brief Article)]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5037/is_200505/ai_n18256647]]></link>
		<description><![CDATA[What do boiling water, snowflakes and flocking birds have in common  with the way we pass each other on the pavement? Philip Ball's  wonderfully intricate "Critical Mass: How One Thing Leads to  Another" (Farrar, Straus and Giroux; William Hei  What do boiling water, snowflakes and flocking...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sat, 21 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Aventis&#39; diabetes initiative targets minorities, doctors]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5351/is_200505/ai_n21371950]]></link>
		<description><![CDATA[ON THE HEELS of a successful pilot program, Aventis will launch a nationwide diabetes awareness effort next month targeting Hispanics and African Americans. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Sun, 01 May 2005 00:00:00 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Pharma MNCs gear up for product patents, recast their portfolios.]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_hb5936/is_200504/ai_n23941719]]></link>
		<description><![CDATA[Byline: Writankar Mukherjee    Apr. 13--KOLKATA, India -- The multinational pharma majors  operating in India have set the ball rolling to improve their  bottomlines in the product patent era.    Many companies have initiated restructuring exercises to strengthen  their presence in key therapeutic...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 13 Apr 2005 23:59:59 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/novartis+ag.html"><![CDATA[Novartis AG]]></category>
		<category domain="http://resources.bnet.com/topic/organon+inc..html"><![CDATA[Organon Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/pfizer+inc..html"><![CDATA[Pfizer Inc.]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">NVS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PFE</category>
		<category domain="tickers">NVS,PFE</category>
	</item>
	<item>
		<title><![CDATA[2005 Aventis general prize longlist revealed]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0KNB/is_2005_March_14/ai_n25105997]]></link>
		<description><![CDATA[M2 BEST BOOKS-C2000-2005 M2 COMMUNICATIONS LTD]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Mon, 14 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Inotek Pharmaceuticals Hires former Aventis and BMS Executive, Dr. Mary Osbakken, as Chief Medical Officer]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_m0EIN/is_2005_March_2/ai_n11838040]]></link>
		<description><![CDATA[BEVERLY, Mass. -- Inotek Pharmaceuticals Corporation announced today that it has hired Dr. Mary Osbakken as Chief Medical Officer. Dr. Osbakken will be broadly responsible for Inotek's clinical development strategy and global clinical operations.]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Wed, 02 Mar 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/mary.html"><![CDATA[Mary]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Sanofi-Aventis posts 18 pct profit rise in 2004, sees in-line 2005]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_kmafp/is_200503/ai_n13268952]]></link>
		<description><![CDATA[PARIS AFP &#8212; Sanofi-Aventis, the French pharmaceutical firm, posted forecast-beating net profit for 2004 and said it expected earnings this year to be in line with the 2004 performance.  Sanofi-Aventis, formed last year in the merger of French firm Sanofi Synthelabo and Franco-German life sciences giant Aventis, said it...]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Mar 2005 23:59:59 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/agence+france-presse.html"><![CDATA[Agence France-Presse]]></category>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/finance.html"><![CDATA[FINANCE]]></category>
		<category domain="http://resources.bnet.com/topic/investment.html"><![CDATA[Investment]]></category>
		<category domain="http://resources.bnet.com/topic/merger.html"><![CDATA[merger]]></category>
		<category domain="http://resources.bnet.com/topic/sanofi-aventis.html"><![CDATA[Sanofi-Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
	<item>
		<title><![CDATA[Novo bolsters its brand team with Aventis execs]]></title>
		<link><![CDATA[http://findarticles.com/p/articles/mi_qa5351/is_200502/ai_n21366662]]></link>
		<description><![CDATA[NOVO NORDISK has appointed a pair of Avenus executives to new communications and brand management posts. ]]></description>
		<s:doctype><![CDATA[Research articles]]></s:doctype>
		<pubDate>Tue, 01 Feb 2005 00:00:00 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/aventis.html"><![CDATA[Aventis]]></category>
		<category domain="http://resources.bnet.com/topic/brand.html"><![CDATA[brand]]></category>
		<category domain="http://resources.bnet.com/topic/team.html"><![CDATA[team]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
	</item>
</channel>
</rss>
